| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -117,576 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Rbc Asset Management Inc | Institution | 2,900 | New Holding | 2,900 | 100 % | $68,411 | $67,889 | $-522 | -0.76 % | $-522 | | | | | | News Article | History of Rbc Asset Management Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | | Sold All | -11,737 | -100 % | | | | 6.40 % | $-16,549 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Growth Fund | Small-Cap Growth | 250 | No Compare | | | $5,500 | $5,853 | $353 | 6.40 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Growth Fund | Small-Cap Growth | 12,625 | No Compare | | | $277,750 | $295,551 | $17,801 | 6.40 % | | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 17,319 | Sold Some | -7,965 | -31.50 % | $374,610 | $405,438 | $30,828 | 8.22 % | $-14,178 | | | | | | News Article | History of Amvescap Plc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-17 | 2009-09-30 | 13F-HR | Castleark Management Llc | Institution | 81,000 | Added More | 25,700 | 46.47 % | $1,752,030 | $1,896,210 | $144,180 | 8.22 % | $45,746 | | | | | | News Article | History of Castleark Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 12,340 | Sold Some | -53,100 | -81.14 % | $266,914 | $288,879 | $21,965 | 8.22 % | $-94,518 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 71,395 | Sold Some | -18,655 | -20.71 % | $1,544,274 | $1,671,357 | $127,083 | 8.22 % | $-33,206 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ah Lisanti Capital Growth Llc | Institution | 103,613 | Added More | 66,350 | 178.05 % | $2,226,643 | $2,425,580 | $198,937 | 8.93 % | $127,392 | | | | | | News Article | History of Ah Lisanti Capital Growth Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 71,334 | Added More | 38 | 0.05 % | $1,532,968 | $1,669,929 | $136,961 | 8.93 % | $73 | | | | | | News Article | History of American International Group Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bay Hill Capital Management Llc | No Data | 31,473 | New Holding | 31,473 | 100 % | $676,355 | $736,783 | $60,428 | 8.93 % | $60,428 | | | | | | News Article | History of Bay Hill Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 6,000 | New Holding | 6,000 | 100 % | $128,940 | $140,460 | $11,520 | 8.93 % | $11,520 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cardinal Capital Management | Institution | 45,943 | Added More | 12,543 | 37.55 % | $987,315 | $1,075,526 | $88,211 | 8.93 % | $24,083 | | | | | | News Article | History of Cardinal Capital Management Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 590,720 | Added More | 514,720 | 677.26 % | $12,694,573 | $13,828,755 | $1,134,182 | 8.93 % | $988,262 | | | | | | News Article | History of Citadel L P Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Cr Intrinsic Investors Llc | Institution | 1,233,380 | New Holding | 1,233,380 | 100 % | $26,505,336 | $28,873,426 | $2,368,090 | 8.93 % | $2,368,090 | | | | | | News Article | History of Cr Intrinsic Investors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Deerfield Management Co | Institution | 4,161,518 | Sold Some | -2,172,968 | -34.30 % | $89,431,022 | $97,421,136 | $7,990,115 | 8.93 % | $-4,172,099 | | | | | | News Article | History of Deerfield Management Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 389,639 | Added More | 387,839 | 21546.61 % | $8,373,342 | $9,121,449 | $748,107 | 8.93 % | $744,651 | | | | | | News Article | History of Fmr Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 110,000 | Added More | 60,000 | 120.00 % | $2,363,900 | $2,575,100 | $211,200 | 8.93 % | $115,200 | | | | | | News Article | History of Galleon Management L P Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Healthcor Management L P | Institution | 1,000,000 | New Holding | 1,000,000 | 100 % | $21,490,000 | $23,410,000 | $1,920,000 | 8.93 % | $1,920,000 | | | | | | News Article | History of Healthcor Management L P Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 74,449 | Added More | 4,659 | 6.67 % | $1,599,909 | $1,742,851 | $142,942 | 8.93 % | $8,945 | | | | | | News Article | History of Ing Groep Nv Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 1,113 | New Holding | 1,113 | 100 % | $23,918 | $26,055 | $2,137 | 8.93 % | $2,137 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Magnetar Financial Llc | Institution | 31,824 | New Holding | 31,824 | 100 % | $683,898 | $745,000 | $61,102 | 8.93 % | $61,102 | | | | | | News Article | History of Magnetar Financial Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 275,000 | Added More | 172,814 | 169.11 % | $5,909,750 | $6,437,750 | $528,000 | 8.93 % | $331,803 | | | | | | News Article | History of Millennium Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 3,673,829 | Sold Some | -722,436 | -16.43 % | $78,950,585 | $86,004,337 | $7,053,752 | 8.93 % | $-1,387,077 | | | | | | News Article | History of Morgan Stanley Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 243,298 | New Holding | 243,298 | 100 % | $5,228,474 | $5,695,606 | $467,132 | 8.93 % | $467,132 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 619,742 | Sold Some | -24,983 | -3.87 % | $13,318,256 | $14,508,160 | $1,189,905 | 8.93 % | $-47,967 | | | | | | News Article | History of Northern Trust Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,300 | Sold Some | -309,341 | -99.58 % | $27,937 | $30,433 | $2,496 | 8.93 % | $-593,935 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | 85,000 | New Holding | 85,000 | 100 % | $1,826,650 | $1,989,850 | $163,200 | 8.93 % | $163,200 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | S Squared Technology Llc | Institution | 1,103,100 | Added More | 815,300 | 283.28 % | $23,705,619 | $25,823,571 | $2,117,952 | 8.93 % | $1,565,376 | | | | | | News Article | History of S Squared Technology Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | 2,600,000 | Added More | 2,492,700 | 2323.11 % | $55,874,000 | $60,866,000 | $4,992,000 | 8.93 % | $4,785,984 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 45,083 | Sold Some | -344,165 | -88.41 % | $968,834 | $1,055,393 | $86,559 | 8.93 % | $-660,797 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sigma Capital Management Llc | Institution | 410,000 | New Holding | 410,000 | 100 % | $8,810,900 | $9,598,100 | $787,200 | 8.93 % | $787,200 | | | | | | News Article | History of Sigma Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Straus Capital Management Llc | Institution | 119,097 | Sold Some | -115,400 | -49.21 % | $2,559,395 | $2,788,061 | $228,666 | 8.93 % | $-221,568 | | | | | | News Article | History of Straus Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 21,132 | New Holding | 21,132 | 100 % | $454,127 | $494,700 | $40,573 | 8.93 % | $40,573 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 3,354 | No Change | 0 | 0 % | $72,077 | $78,517 | $6,440 | 8.93 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Visium Asset Management Llc | Institution | 2,503,872 | Added More | 2,108,738 | 533.67 % | $53,808,209 | $58,615,644 | $4,807,434 | 8.93 % | $4,048,777 | | | | | | News Article | History of Visium Asset Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 140,000 | Added More | 88,800 | 173.43 % | $3,008,600 | $3,277,400 | $268,800 | 8.93 % | $170,496 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 5,050,626 | Sold Some | -1,148,460 | -18.52 % | $108,537,953 | $118,235,155 | $9,697,202 | 8.93 % | $-2,205,043 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-16 | 2009-06-30 | 13F-HR/A | Highland Capital Management Lp | Institution | | Sold All | -59,134 | -100 % | | | | 8.93 % | $-113,537 | | | | | | News Article | History of Highland Capital Management Lp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 43,730 | Sold Some | -15,423 | -26.07 % | $909,147 | $1,023,719 | $114,573 | 12.60 % | $-40,408 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 126,416 | Sold Some | -18,670 | -12.86 % | $2,628,189 | $2,959,399 | $331,210 | 12.60 % | $-48,915 | | | | | | News Article | History of Axa Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 547,793 | Added More | 513,085 | 1478.29 % | $11,388,616 | $12,823,834 | $1,435,218 | 12.60 % | $1,344,283 | | | | | | News Article | History of Barclays Plc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 17,088 | New Holding | 17,088 | 100 % | $355,260 | $400,030 | $44,771 | 12.60 % | $44,771 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 25,053 | New Holding | 25,053 | 100 % | $520,852 | $586,491 | $65,639 | 12.60 % | $65,639 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 190,000 | New Holding | 190,000 | 100 % | $3,950,100 | $4,447,900 | $497,800 | 12.60 % | $497,800 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Expo Capital Management Llc | Institution | 230,000 | New Holding | 230,000 | 100 % | $4,781,700 | $5,384,300 | $602,600 | 12.60 % | $602,600 | | | | | | News Article | History of Expo Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 735 | Sold Some | -36,135 | -98.00 % | $15,281 | $17,206 | $1,926 | 12.60 % | $-94,674 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 127,957 | Added More | 3,590 | 2.88 % | $2,660,226 | $2,995,473 | $335,247 | 12.60 % | $9,406 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 127,466 | Sold Some | -51,180 | -28.64 % | $2,650,018 | $2,983,979 | $333,961 | 12.60 % | $-134,092 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Investment Counsel Llc | Institution | 86 | No Change | 0 | 0 % | $1,788 | $2,013 | $225 | 12.60 % | $0 | | | | | | News Article | History of Legg Mason Investment Counsel Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 420,737 | New Holding | 420,737 | 100 % | $8,747,122 | $9,849,453 | $1,102,331 | 12.60 % | $1,102,331 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mason Street Advisors Llc | Institution | 3,014 | Added More | 124 | 4.29 % | $62,661 | $70,558 | $7,897 | 12.60 % | $325 | | | | | | News Article | History of Mason Street Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 94,980 | No Change | 0 | 0 % | $1,974,634 | $2,223,482 | $248,848 | 12.60 % | $0 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 600 | No Change | 0 | 0 % | $12,474 | $14,046 | $1,572 | 12.60 % | $0 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 71,373 | Added More | 59,600 | 506.24 % | $1,483,845 | $1,670,842 | $186,997 | 12.60 % | $156,152 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Public Sector Pension Investment Board | Institution | 44,200 | New Holding | 44,200 | 100 % | $918,918 | $1,034,722 | $115,804 | 12.60 % | $115,804 | | | | | | News Article | History of Public Sector Pension Investment Board Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -6,144 | -100 % | | | | 12.60 % | $-16,097 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 7,644 | Added More | 7,258 | 1880.31 % | $158,919 | $178,946 | $20,027 | 12.60 % | $19,016 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 72,800 | Sold Some | -52,300 | -41.80 % | $1,513,512 | $1,704,248 | $190,736 | 12.60 % | $-137,026 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Research Affiliates Llc | Institution | 9,597 | New Holding | 9,597 | 100 % | $199,522 | $224,666 | $25,144 | 12.60 % | $25,144 | | | | | | News Article | History of Research Affiliates Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 34,609 | New Holding | 34,609 | 100 % | $719,521 | $810,197 | $90,676 | 12.60 % | $90,676 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Shapiro Capital Management Co Inc | Institution | | Sold All | -3,882,156 | -100 % | | | | 12.60 % | $-10,171,249 | | | | | | News Article | History of Shapiro Capital Management Co Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 2,108,736 | Added More | 50,924 | 2.47 % | $43,840,621 | $49,365,510 | $5,524,888 | 12.60 % | $133,421 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | | Sold All | -31,900 | -100 % | | | | 15.83 % | $-102,080 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 183,410 | Sold Some | -1,760 | -0.95 % | $3,706,716 | $4,293,628 | $586,912 | 15.83 % | $-5,632 | | | | | | News Article | History of Bank Of America Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 4,086,119 | Added More | 361,994 | 9.72 % | $82,580,465 | $95,656,046 | $13,075,581 | 15.83 % | $1,158,381 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 795,900 | Added More | 145,800 | 22.42 % | $16,085,139 | $18,632,019 | $2,546,880 | 15.83 % | $466,560 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Charles Schwab Trust Company A Division Of Charles Schwab B | No Data | 36,730 | New Holding | 36,730 | 100 % | $742,313 | $859,849 | $117,536 | 15.83 % | $117,536 | | | | | | News Article | History of Charles Schwab Trust Company A Division Of Charles Schwab B Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 10,168 | New Holding | 10,168 | 100 % | $205,495 | $238,033 | $32,538 | 15.83 % | $32,538 | | | | | | News Article | History of Credit Suisse Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 300,000 | Sold Some | -100,000 | -25.00 % | $6,063,000 | $7,023,000 | $960,000 | 15.83 % | $-320,000 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Engemann Asset Management | Institution | 562 | No Change | 0 | 0 % | $11,358 | $13,156 | $1,798 | 15.83 % | $0 | | | | | | News Article | History of Engemann Asset Management Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 24,920 | Sold Some | -43,270 | -63.45 % | $503,633 | $583,377 | $79,744 | 15.83 % | $-138,464 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 6,615 | Added More | 2,742 | 70.79 % | $133,689 | $154,857 | $21,168 | 15.83 % | $8,774 | | | | | | News Article | History of Kbc Group Nv Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Liberty Mutual Insurance Co | Institution | | Sold All | -33,800 | -100 % | | | | 15.83 % | $-108,160 | | | | | | News Article | History of Liberty Mutual Insurance Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 50 | Sold Some | -8,838 | -99.43 % | $1,011 | $1,171 | $160 | 15.83 % | $-28,282 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 48,409 | Added More | 4,259 | 9.64 % | $978,346 | $1,133,255 | $154,909 | 15.83 % | $13,629 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mycio Wealth Partners Llc | Institution | 930 | Added More | 391 | 72.54 % | $18,795 | $21,771 | $2,976 | 15.83 % | $1,251 | | | | | | News Article | History of Mycio Wealth Partners Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 9,795 | Added More | 2,161 | 28.30 % | $197,957 | $229,301 | $31,344 | 15.83 % | $6,915 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 5,677 | Added More | 79 | 1.41 % | $114,732 | $132,899 | $18,166 | 15.83 % | $253 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 176,268 | Added More | 2,971 | 1.71 % | $3,562,376 | $4,126,434 | $564,058 | 15.83 % | $9,507 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rice Hall James And Associates Llc | Institution | 17,373 | No Change | 0 | 0 % | $351,108 | $406,702 | $55,594 | 15.83 % | $0 | | | | | | News Article | History of Rice Hall James And Associates Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sector Gamma Asa | No Data | 276,084 | No Compare | | | $5,579,658 | $6,463,126 | $883,469 | 15.83 % | | | | | | | News Article | History of Sector Gamma Asa Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 94,305 | New Holding | 94,305 | 100 % | $1,905,904 | $2,207,680 | $301,776 | 15.83 % | $301,776 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 27,318 | Sold Some | -2,546 | -8.52 % | $552,097 | $639,514 | $87,418 | 15.83 % | $-8,147 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 82,600 | Added More | 16,700 | 25.34 % | $1,669,346 | $1,933,666 | $264,320 | 15.83 % | $53,440 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 74,590 | New Holding | 74,590 | 100 % | $1,497,767 | $1,746,152 | $248,385 | 16.58 % | $248,385 | | | | | | News Article | History of American Century Companies Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 4,801,442 | No Change | 0 | 0 % | $96,412,955 | $112,401,757 | $15,988,802 | 16.58 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 77,034 | Sold Some | -107,675 | -58.29 % | $1,546,843 | $1,803,366 | $256,523 | 16.58 % | $-358,558 | | | | | | News Article | History of Citigroup Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 57,485 | Added More | 2,294 | 4.15 % | $1,154,299 | $1,345,724 | $191,425 | 16.58 % | $7,639 | | | | | | News Article | History of Comerica Bank Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 75,769 | Added More | 18,983 | 33.42 % | $1,521,442 | $1,773,752 | $252,311 | 16.58 % | $63,213 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | | Sold All | -1,752 | -100 % | | | | 16.58 % | $-5,834 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 91,882 | Added More | 28,305 | 44.52 % | $1,844,991 | $2,150,958 | $305,967 | 16.58 % | $94,256 | | | | | | News Article | History of Ubs Ag Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Cadence Capital Management Llc | Institution | | Sold All | -51,490 | -100 % | | | | 10.73 % | $-116,882 | | | | | | News Article | History of Cadence Capital Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 2,700 | No Change | 0 | 0 % | $57,078 | $63,207 | $6,129 | 10.73 % | $0 | | | | | | News Article | History of Ccm Partners Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 65,180 | Sold Some | -5,400 | -7.65 % | $1,377,905 | $1,525,864 | $147,959 | 10.73 % | $-12,258 | | | | | | News Article | History of Federated Investors Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | N-Q | Forum Funds - Adams Harkness Small Cap Growth Fund | Small-Cap Growth | 8,365 | Added More | 5,225 | 166.40 % | $176,836 | $195,825 | $18,989 | 10.73 % | $11,861 | | | | | | News Article | History of Forum Funds - Adams Harkness Small Cap Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Goldman Jay G | Institution | 480,000 | New Holding | 480,000 | 100 % | $10,147,200 | $11,236,800 | $1,089,600 | 10.73 % | $1,089,600 | | | | | | News Article | History of Goldman Jay G Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Missouri Valley Partners Inc | Institution | 27,438 | Sold Some | -10,482 | -27.64 % | $580,039 | $642,324 | $62,284 | 10.73 % | $-23,794 | | | | | | News Article | History of Missouri Valley Partners Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-09 | 2009-09-30 | 13F-HR | Vtl Associates Llc | Institution | | Sold All | -3 | -100 % | | | | 10.73 % | $-7 | | | | | | News Article | History of Vtl Associates Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | | Sold All | -11,667 | -100 % | | | | 11.79 % | $-28,817 | | | | | | News Article | History of Blair William And Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 7,933 | Added More | 50 | 0.63 % | $166,117 | $185,712 | $19,595 | 11.79 % | $124 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 42,419 | No Change | 0 | 0 % | $888,254 | $993,029 | $104,775 | 11.79 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | | Sold All | -190,000 | -100 % | | | | 11.79 % | $-469,300 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 66 | Sold Some | -22 | -25.00 % | $1,382 | $1,545 | $163 | 11.79 % | $-54 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 83,944 | Sold Some | -25,000 | -22.94 % | $1,757,787 | $1,965,129 | $207,342 | 11.79 % | $-61,750 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 52,893 | Sold Some | -2,230 | -4.04 % | $1,107,579 | $1,238,225 | $130,646 | 11.79 % | $-5,508 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 340,253 | Added More | 370 | 0.10 % | $7,124,898 | $7,965,323 | $840,425 | 11.79 % | $914 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | 28,000 | Sold Some | -37,400 | -57.18 % | $590,240 | $655,480 | $65,240 | 11.05 % | $-87,142 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 51,800 | No Change | 0 | 0 % | $1,091,944 | $1,212,638 | $120,694 | 11.05 % | $0 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 35,239 | Added More | 548 | 1.57 % | $742,838 | $824,945 | $82,107 | 11.05 % | $1,277 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 17,723 | Added More | 2,878 | 19.38 % | $373,601 | $414,895 | $41,295 | 11.05 % | $6,706 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 19,638 | Sold Some | -6,600 | -25.15 % | $413,969 | $459,726 | $45,757 | 11.05 % | $-15,378 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 40,826 | Added More | 14,673 | 56.10 % | $818,970 | $955,737 | $136,767 | 16.69 % | $49,155 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 1,520 | Sold Some | -580 | -27.61 % | $30,491 | $35,583 | $5,092 | 16.69 % | $-1,943 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-09-30 | 13F-HR | Private Trust Co Na | Institution | | Sold All | -57 | -100 % | | | | 17.05 % | $-194 | | | | | | News Article | History of Private Trust Co Na Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 92,310 | Added More | 3,043 | 3.40 % | $1,846,200 | $2,160,977 | $314,777 | 17.05 % | $10,377 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Management Llc | Institution | 32,940 | New Holding | 32,940 | 100 % | $658,800 | $771,125 | $112,325 | 17.05 % | $112,325 | | | | | | News Article | History of Turner Investment Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 274,826 | New Holding | 274,826 | 100 % | $5,496,520 | $6,433,677 | $937,157 | 17.05 % | $937,157 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - S And P Smallcap Index Fund | Small-Cap Core | 2,700 | No Change | 0 | 0 % | $54,000 | $63,207 | $9,207 | 17.05 % | $0 | | | | | | News Article | History of California Investment Trust - S And P Smallcap Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-03 | 2009-08-31 | N-CSRS | Wells Fargo Funds Trust - Money Market Fund | Specialty & Misc | | Sold All | -61,618 | -100 % | | | | 17.05 % | $-210,117 | | | | | | News Article | History of Wells Fargo Funds Trust - Money Market Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 25,100 | Sold Some | -26,300 | -51.16 % | $477,151 | $587,591 | $110,440 | 23.14 % | $-115,720 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 20,000 | New Holding | 20,000 | 100 % | $380,200 | $468,200 | $88,000 | 23.14 % | $88,000 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 99,767 | Added More | 60,019 | 150.99 % | $1,834,715 | $2,335,545 | $500,830 | 27.29 % | $301,295 | | | | | | News Article | History of Oxford Asset Management Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-30 | 2009-09-30 | 13F-HR | Texas Permanent School Fund | Institution | 78,425 | Added More | 247 | 0.31 % | $1,442,236 | $1,835,929 | $393,694 | 27.29 % | $1,240 | | | | | | News Article | History of Texas Permanent School Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 499,673 | Sold Some | -1,256,680 | -71.55 % | $9,188,986 | $11,697,345 | $2,508,358 | 27.29 % | $-6,308,534 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 2,026 | No Compare | | | $37,258 | $47,429 | $10,171 | 27.29 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 21,877 | Sold Some | -627 | -2.78 % | $402,318 | $512,141 | $109,823 | 27.29 % | $-3,148 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 854,465 | Sold Some | -919,701 | -51.83 % | $16,431,362 | $20,003,026 | $3,571,664 | 21.73 % | $-3,844,350 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -4,400 | -100 % | | | | 21.73 % | $-18,392 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -1,300 | -100 % | | | | 21.73 % | $-5,434 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Asset Allocation Fund | Specialty & Misc | 180 | New Holding | 180 | 100 % | $3,461 | $4,214 | $752 | 21.73 % | $752 | | | | | | News Article | History of Valic Co I - Asset Allocation Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 39,006 | New Holding | 39,006 | 100 % | $750,085 | $913,130 | $163,045 | 21.73 % | $163,045 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 72,000 | New Holding | 72,000 | 100 % | $1,353,600 | $1,685,520 | $331,920 | 24.52 % | $331,920 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 59,153 | Sold Some | -9,344 | -13.64 % | $1,193,708 | $1,384,772 | $191,064 | 16.00 % | $-30,181 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-23 | 2009-09-30 | 13F-HR | Columbus Circle Investors | Institution | 98,261 | New Holding | 98,261 | 100 % | $2,014,351 | $2,300,290 | $285,940 | 14.19 % | $285,940 | | | | | | News Article | History of Columbus Circle Investors Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 16,430 | No Change | 0 | 0 % | $343,387 | $384,626 | $41,239 | 12.00 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -16,450 | -100 % | | | | 12.00 % | $-41,290 | | | | | | News Article | History of Blackrock Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 167,024 | Added More | 23,969 | 16.75 % | $3,490,802 | $3,910,032 | $419,230 | 12.00 % | $60,162 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 785,954 | Added More | 317,182 | 67.66 % | $15,836,973 | $18,399,183 | $2,562,210 | 16.17 % | $1,034,013 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 81,162 | Added More | 20,848 | 34.56 % | $1,635,414 | $1,900,002 | $264,588 | 16.17 % | $67,964 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 21,750 | No Change | 0 | 0 % | $455,228 | $509,168 | $53,940 | 11.84 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 87,900 | Sold Some | -22,300 | -20.23 % | $1,839,747 | $2,057,739 | $217,992 | 11.84 % | $-55,304 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-19 | 2009-09-30 | 13F-HR | Hanseatic Management Services Inc | Institution | 16,000 | No Change | 0 | 0 % | $340,320 | $374,560 | $34,240 | 10.06 % | $0 | | | | | | News Article | History of Hanseatic Management Services Inc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 17,700 | Sold Some | -83,000 | -82.42 % | $376,479 | $414,357 | $37,878 | 10.06 % | $-177,620 | | | | | | News Article | History of Strs Ohio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 20,510 | No Change | 0 | 0 % | $455,937 | $480,139 | $24,202 | 5.30 % | $0 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 58,774 | No Change | 0 | 0 % | $1,347,688 | $1,375,899 | $28,212 | 2.09 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-14 | 2009-09-30 | 13F-HR | Dorsey Wright Associates | Institution | 45 | No Change | 0 | 0 % | $1,046 | $1,053 | $7 | 0.68 % | $0 | | | | | | News Article | History of Dorsey Wright Associates Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 85,680 | Sold Some | -652 | -0.75 % | $1,956,931 | $2,005,769 | $48,838 | 2.49 % | $-372 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 6,284 | Sold Some | -14,516 | -69.78 % | $148,994 | $147,108 | $-1,885 | -1.26 % | $4,355 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Small Cap Fund | Small-Cap Value | 60,500 | Sold Some | -22,800 | -27.37 % | $1,332,210 | $1,416,305 | $84,095 | 6.31 % | $-31,692 | | | | | | News Article | History of Pacific Capital Funds - Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-02 | 2009-07-31 | N-CSR | Riversource Dimensions Series Inc - Riversource Disciplined Small Cap Value Fund | Small-Cap Value | | Sold All | -8,528 | -100 % | | | | 6.31 % | $-11,854 | | | | | | News Article | History of Riversource Dimensions Series Inc - Riversource Disciplined Small Cap Value Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 1,300 | New Holding | 1,300 | 100 % | $28,626 | $30,433 | $1,807 | 6.31 % | $1,807 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 95,868 | No Change | 0 | 0 % | $2,026,650 | $2,244,270 | $217,620 | 10.73 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 29,902 | New Holding | 29,902 | 100 % | $632,128 | $700,006 | $67,878 | 10.73 % | $67,878 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 900 | No Change | 0 | 0 % | $19,026 | $21,069 | $2,043 | 10.73 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Va Small Value Portfolio | Small-Cap Value | 210,893 | New Holding | 210,893 | 100 % | $4,458,278 | $4,937,005 | $478,727 | 10.73 % | $478,727 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Va Small Value Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - The Hartford Global Enhanced Dividend Fund | No Data | 2 | No Compare | | | $42 | $47 | $5 | 10.73 % | | | | | | | News Article | History of Hartford Mutual Funds Incct - The Hartford Global Enhanced Dividend Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 641 | No Change | 0 | 0 % | $13,551 | $15,006 | $1,455 | 10.73 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -3,300 | -100 % | | | | 11.37 % | $-7,887 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -6,000 | -100 % | | | | 11.37 % | $-14,340 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 5,304 | No Change | 0 | 0 % | $111,490 | $124,167 | $12,677 | 11.37 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 12,255 | New Holding | 12,255 | 100 % | $257,600 | $286,890 | $29,289 | 11.37 % | $29,289 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | 25,000 | New Holding | 25,000 | 100 % | $525,500 | $585,250 | $59,750 | 11.37 % | $59,750 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | 9,695 | New Holding | 9,695 | 100 % | $203,789 | $226,960 | $23,171 | 11.37 % | $23,171 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-28 | 2009-07-31 | N-Q | Tocqueville Trust - The Tocqueville Fund | Specialty & Misc | 72,700 | New Holding | 72,700 | 100 % | $1,528,154 | $1,701,907 | $173,753 | 11.37 % | $173,753 | | | | | | News Article | History of Tocqueville Trust - The Tocqueville Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 3,873 | Added More | 634 | 19.57 % | $78,080 | $90,667 | $12,587 | 16.12 % | $2,061 | | | | | | News Article | History of Kbc Group Nv Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 1,030 | New Holding | 1,030 | 100 % | $20,301 | $24,112 | $3,811 | 18.77 % | $3,811 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - S And P Smallcap 600 Pure Growth Etf | Small-Cap Growth | 2,749 | New Holding | 2,749 | 100 % | $54,183 | $64,354 | $10,171 | 18.77 % | $10,171 | | | | | | News Article | History of Rydex Etf Trust - S And P Smallcap 600 Pure Growth Etf Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -200 | -100 % | | | | 18.29 % | $-724 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Value Portfolio | Small-Cap Value | | Sold All | -1,800 | -100 % | | | | 18.29 % | $-6,516 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Value Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-15 | 2008-03-31 | 13F-HR/A | Segall Bryant And Hamill | Institution | | Sold All | -574,821 | -100 % | | | | 18.29 % | $-2,080,852 | | | | | | News Article | History of Segall Bryant And Hamill Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,724,125 | Sold Some | -253,596 | -6.37 % | $49,828,793 | $87,181,766 | $37,352,974 | 74.96 % | $-2,543,568 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-08 | 2009-06-30 | N-CSR | Revenueshares Etf Trust - Revenueshares Small Cap Fund | Small-Cap Core | 838 | Added More | 468 | 126.48 % | $10,886 | $19,618 | $8,732 | 80.21 % | $4,877 | | | | | | News Article | History of Revenueshares Etf Trust - Revenueshares Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 5,598 | Added More | 531 | 10.47 % | $72,718 | $131,049 | $58,331 | 80.21 % | $5,533 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 5,104 | Added More | 4,724 | 1243.15 % | $66,301 | $119,485 | $53,184 | 80.21 % | $49,224 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 26,800 | New Holding | 26,800 | 100 % | $340,896 | $627,388 | $286,492 | 84.04 % | $286,492 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio | Small-Cap Value | | Sold All | -56,300 | -100 % | | | | 84.04 % | $-601,847 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Value Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 31,500 | No Change | 0 | 0 % | $400,680 | $737,415 | $336,735 | 84.04 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 8,580 | New Holding | 8,580 | 100 % | $109,138 | $200,858 | $91,720 | 84.04 % | $91,720 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 108,856 | Added More | 48,080 | 79.11 % | $1,384,648 | $2,548,319 | $1,163,671 | 84.04 % | $513,975 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 13 | No Change | 0 | 0 % | $165 | $304 | $139 | 84.04 % | $0 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 13 | Added More | 2 | 18.18 % | $165 | $304 | $139 | 84.04 % | $21 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Value Fund | Small-Cap Core | 31,250 | Sold Some | -475 | -1.49 % | $397,500 | $731,563 | $334,063 | 84.04 % | $-5,078 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Value Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 20,800 | Added More | 14,193 | 214.81 % | $264,576 | $486,928 | $222,352 | 84.04 % | $151,723 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 5,530 | Added More | 330 | 6.34 % | $70,342 | $129,457 | $59,116 | 84.04 % | $3,528 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 30,387 | New Holding | 30,387 | 100 % | $386,523 | $711,360 | $324,837 | 84.04 % | $324,837 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-30 | N-CSRS | Westcore Trust - Westcore Micro-Cap Opportunity Fund | No Data | | Sold All | -857 | -100 % | | | | 84.04 % | $-9,161 | | | | | | News Article | History of Westcore Trust - Westcore Micro-Cap Opportunity Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-04 | 2009-06-10 | N-CSRS | Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Balanced Portfolio | Flexible Portfolio | 1,800 | New Holding | 1,800 | 100 % | $22,896 | $42,138 | $19,242 | 84.04 % | $19,242 | | | | | | News Article | History of Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Balanced Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Small Cap Index Fund | Small-Cap Core | 5,200 | Added More | 200 | 4.00 % | $65,052 | $121,732 | $56,680 | 87.13 % | $2,180 | | | | | | News Article | History of Mml Series Investment Fund - Mml Small Cap Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 4,760 | Added More | 1,530 | 47.36 % | $59,548 | $111,432 | $51,884 | 87.13 % | $16,677 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-03 | 2009-06-30 | N-CSR | New Covenant Funds - New Covenant Growth Fund | No Data | | Sold All | -16,200 | -100 % | | | | 87.13 % | $-176,580 | | | | | | News Article | History of New Covenant Funds - New Covenant Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 872 | No Compare | | | $10,909 | $20,414 | $9,505 | 87.13 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -9,014 | -100 % | | | | 87.13 % | $-98,253 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-02 | 2009-06-30 | N-CSRS | Schwab Capital Trust - Schwab Technology Fund | Science & Tech | | Sold All | -9,995 | -100 % | | | | 91.72 % | $-111,944 | | | | | | News Article | History of Schwab Capital Trust - Schwab Technology Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 25,284 | Sold Some | -93,740 | -78.75 % | $306,695 | $591,898 | $285,204 | 92.99 % | $-1,057,387 | | | | | | News Article | History of Amvescap Plc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 1,800 | Sold Some | -258,200 | -99.30 % | $21,834 | $42,138 | $20,304 | 92.99 % | $-2,912,496 | | | | | | News Article | History of Fmr Corp Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -3,000 | -100 % | | | | 87.13 % | $-32,700 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 581 | Added More | 199 | 52.09 % | $7,268 | $13,601 | $6,333 | 87.13 % | $2,169 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Ccm Emerging Companies | Small-Cap Growth | 30,100 | Sold Some | -57,470 | -65.62 % | $377,755 | $704,641 | $326,886 | 86.53 % | $-624,124 | | | | | | News Article | History of Allianz Funds - Ccm Emerging Companies Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 467,660 | Sold Some | -18,310 | -3.76 % | $5,869,133 | $10,947,921 | $5,078,788 | 86.53 % | $-198,847 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 341,067 | New Holding | 341,067 | 100 % | $4,280,391 | $7,984,378 | $3,703,988 | 86.53 % | $3,703,988 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 580,841 | Sold Some | -11,599 | -1.95 % | $7,289,555 | $13,597,488 | $6,307,933 | 86.53 % | $-125,965 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Value Index Fund | Multi-Cap Value | | Sold All | -388,343 | -100 % | | | | 86.53 % | $-4,217,405 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Value Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 3,006 | New Holding | 3,006 | 100 % | $37,725 | $70,370 | $32,645 | 86.53 % | $32,645 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 12,490 | Added More | 720 | 6.11 % | $156,750 | $292,391 | $135,641 | 86.53 % | $7,819 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Value Index Fund | Multi-Cap Value | | Sold All | -3,187 | -100 % | | | | 86.53 % | $-34,611 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Value Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | | Sold All | -59,237 | -100 % | | | | 86.53 % | $-643,314 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Small Cap Portfolio | Small-Cap Core | 6,807 | New Holding | 6,807 | 100 % | $85,428 | $159,352 | $73,924 | 86.53 % | $73,924 | | | | | | News Article | History of Seasons Series Trust - Small Cap Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | N-CSRS/A | Tiff Investment Program Inc - Tiff Us Equity Fund | Specialty & Misc | | Sold All | -84,200 | -100 % | | | | 86.53 % | $-914,412 | | | | | | News Article | History of Tiff Investment Program Inc - Tiff Us Equity Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 90,050 | Sold Some | -17,543 | -16.30 % | $1,130,128 | $2,108,071 | $977,943 | 86.53 % | $-190,517 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | | Sold All | -77,800 | -100 % | | | | 86.53 % | $-844,908 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | | Sold All | -31,200 | -100 % | | | | 86.53 % | $-338,832 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Lifecycle Long Range Fund | Mixed-Asset Target Allocation Moderate | | Sold All | -1,700 | -100 % | | | | 82.32 % | $-17,969 | | | | | | News Article | History of Dws Advisor Funds - Dws Lifecycle Long Range Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 32,544 | Added More | 2,340 | 7.74 % | $417,865 | $761,855 | $343,990 | 82.32 % | $24,734 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 294,819 | New Holding | 294,819 | 100 % | $3,785,476 | $6,901,713 | $3,116,237 | 82.32 % | $3,116,237 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 371,028 | New Holding | 371,028 | 100 % | $4,764,000 | $8,685,765 | $3,921,766 | 82.32 % | $3,921,766 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 458,397 | New Holding | 458,397 | 100 % | $5,885,817 | $10,731,074 | $4,845,256 | 82.32 % | $4,845,256 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2009-06-30 | N-Q | Wells Fargo Master Trust - Index Portfolio | Specialty & Misc | 30,788 | Sold Some | -21 | -0.06 % | $395,318 | $720,747 | $325,429 | 82.32 % | $-222 | | | | | | News Article | History of Wells Fargo Master Trust - Index Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 16,058 | No Change | 0 | 0 % | $206,185 | $375,918 | $169,733 | 82.32 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 27,558 | Added More | 11,500 | 71.61 % | $353,845 | $645,133 | $291,288 | 82.32 % | $121,555 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 400,000 | Sold Some | -450,000 | -52.94 % | $5,152,000 | $9,364,000 | $4,212,000 | 81.75 % | $-4,738,500 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Funds Group Trust - Touchstone Small Cap Fund | Small-Cap Core | 18,775 | Sold Some | -175 | -0.92 % | $241,822 | $439,523 | $197,701 | 81.75 % | $-1,843 | | | | | | News Article | History of Touchstone Funds Group Trust - Touchstone Small Cap Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-25 | 2009-06-30 | N-CSRS | Forum Funds - Adams Harkness Small Cap Growth Fund | Small-Cap Growth | 3,140 | New Holding | 3,140 | 100 % | $40,035 | $73,507 | $33,472 | 83.60 % | $33,472 | | | | | | News Article | History of Forum Funds - Adams Harkness Small Cap Growth Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-25 | 2009-06-30 | N-Q | Laudus Trust - Laudus Rosenberg International Small Capitalization Fund | Small-Cap Core | | Sold All | -14,870 | -100 % | | | | 83.60 % | $-158,514 | | | | | | News Article | History of Laudus Trust - Laudus Rosenberg International Small Capitalization Fund Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-25 | 2009-06-30 | N-CSRS | Premier Vit - Opcap Small Cap Portfolio | Small-Cap Core | 13,500 | New Holding | 13,500 | 100 % | $172,125 | $316,035 | $143,910 | 83.60 % | $143,910 | | | | | | News Article | History of Premier Vit - Opcap Small Cap Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 27,600 | New Holding | 27,600 | 100 % | $357,972 | $646,116 | $288,144 | 80.49 % | $288,144 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Salix Pharmaceuticals Ltd |
RSS feed for SLXP